Thermal proteomics combined with mass spectrometry reveals functional pathways and resistance signals from drug-induced protein-stability changes.
Nature Communications
MS-CETSA combines drug treatment, thermal stability profiling and quantitative mass spectrometry to connect protein-stability shifts with programs such as DNA repair.
Experiments should standardize cell state, exposure, temperature range, protein quantification and replicates, followed by orthogonal validation of candidates.